Jiang Yin

InstitutionAffiliated Cancer Hospital & Institute of Guangzhou Medical University
AddressGuangzhou
Guangdong
China
vCardDownload vCard
    Publication Timeline
    COVID-19 publications
    Bar chart showing 1 Covid-19 publications, with a maximum of 1 publications in July 2021
    All Publications
    Bar chart showing 48 publications over 15 distinct years, with a maximum of 5 publications in 2007 and 2013 and 2015 and 2017
    These graphs show COVID-19 publications by month since August 2019 and all publications written by authors of COVID-19 publications over the past 30 years.

    To see the data from both graphs as text, click here.
    Publication Field Summary
    This graph shows the number and percent of publications by field. Fields are based on how the National Library of Medicine (NLM) classifies the publications' journals and might not represent the specific topics of the publications. Note that an individual publication can be assigned to more than one field. As a result, the publication counts in this graph might add up to more than the number of publications the person has written. To see the data as text, click here.
    Publication List
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications.
    Sort By:     Newest   |   Oldest   |   Most Cited   |   Most Discussed
    PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.
    1. Baral PK, Yin J, James MNG. Treatment and prevention strategies for the COVID 19 pandemic: A review of immunotherapeutic approaches for neutralizing SARS-CoV-2. Int J Biol Macromol. 2021 Sep 01; 186:490-500. PMID: 34237371.
      Citations:    Fields:    Translation:HumansPHPublic Health
    2. Huitema C, Zhang J, Yin J, James MN, Vederas JC, Eltis LD. Heteroaromatic ester inhibitors of hepatitis A virus 3C proteinase: Evaluation of mode of action. Bioorg Med Chem. 2008 May 15; 16(10):5761-77. PMID: 18407505.
      Citations: 5     Fields:    Translation:Cells
    3. Zhang J, Huitema C, Niu C, Yin J, James MN, Eltis LD, Vederas JC. Aryl methylene ketones and fluorinated methylene ketones as reversible inhibitors for severe acute respiratory syndrome (SARS) 3C-like proteinase. Bioorg Chem. 2008 Oct; 36(5):229-40. PMID: 18295820.
      Citations: 11     Fields:    Translation:Cells
    4. Niu C, Yin J, Zhang J, Vederas JC, James MN. Molecular docking identifies the binding of 3-chloropyridine moieties specifically to the S1 pocket of SARS-CoV Mpro. Bioorg Med Chem. 2008 Jan 01; 16(1):293-302. PMID: 17931870.
      Citations: 13     Fields:    Translation:HumansCells
    5. Yin J, Niu C, Cherney MM, Zhang J, Huitema C, Eltis LD, Vederas JC, James MN. A mechanistic view of enzyme inhibition and peptide hydrolysis in the active site of the SARS-CoV 3C-like peptidase. J Mol Biol. 2007 Aug 24; 371(4):1060-74. PMID: 17599357.
      Citations: 18     Fields:    Translation:Cells
    6. Zhang J, Pettersson HI, Huitema C, Niu C, Yin J, James MN, Eltis LD, Vederas JC. Design, synthesis, and evaluation of inhibitors for severe acute respiratory syndrome 3C-like protease based on phthalhydrazide ketones or heteroaromatic esters. J Med Chem. 2007 Apr 19; 50(8):1850-64. PMID: 17381079.
      Citations: 28     Fields:    Translation:Cells